Sumitomo Mitsui Trust Holdings Inc. Grows Stock Holdings in Encompass Health Co. (NYSE:EHC)

Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of Encompass Health Co. (NYSE:EHC) by 2.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,318,784 shares of the company’s stock after buying an additional 29,926 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about 1.32% of Encompass Health worth $87,989,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Encompass Health in the fourth quarter valued at approximately $30,000. C M Bidwell & Associates Ltd. acquired a new stake in shares of Encompass Health in the third quarter valued at approximately $35,000. Worth Asset Management LLC acquired a new stake in shares of Encompass Health in the first quarter valued at approximately $35,000. Belpointe Asset Management LLC grew its position in shares of Encompass Health by 88.2% in the first quarter. Belpointe Asset Management LLC now owns 781 shares of the company’s stock valued at $42,000 after purchasing an additional 366 shares during the last quarter. Finally, Quarry LP acquired a new stake in shares of Encompass Health in the first quarter valued at approximately $42,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

NYSE:EHC opened at $79.71 on Thursday. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The company has a market cap of $7.98 billion, a P/E ratio of 22.97, a P/E/G ratio of 1.50 and a beta of 0.94. Encompass Health Co. has a fifty-two week low of $57.55 and a fifty-two week high of $83.73. The firm’s 50 day moving average is $77.15 and its two-hundred day moving average is $70.16.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.12. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. The company had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. Analysts expect that Encompass Health Co. will post 3.96 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s dividend payout ratio is presently 17.29%.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Barclays raised their target price on shares of Encompass Health from $95.00 to $101.00 and gave the stock an “overweight” rating in a research report on Thursday, March 28th. Stephens restated an “overweight” rating and set a $85.00 target price on shares of Encompass Health in a research report on Tuesday, January 16th. Royal Bank of Canada restated an “outperform” rating and set a $83.00 target price on shares of Encompass Health in a research report on Friday, February 9th. Truist Financial raised their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Finally, Mizuho raised their target price on shares of Encompass Health from $77.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $83.22.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.